e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
What's new in pulmonary rehabilitation and chronic care in 2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Compliance with guidelines for pharmacological treatment of COPD: Real-life analyses
F. Franssen, M. Spruit, J. Does, E. Rutten, E. Wouters (Horn, Netherlands)
Source:
Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010
Session:
What's new in pulmonary rehabilitation and chronic care in 2010
Session type:
Oral Presentation
Number:
3656
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Franssen, M. Spruit, J. Does, E. Rutten, E. Wouters (Horn, Netherlands). Compliance with guidelines for pharmacological treatment of COPD: Real-life analyses. Eur Respir J 2010; 36: Suppl. 54, 3656
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Efficacy and safety of antibiotic treatment of stable COPD
Source: Annual Congress 2010 - Treatment of bronchial infection: beyond the exacerbations
Year: 2010
Evaluating cardiac safety of tiotropium in patients with COPD: Combined analysis of Holter-ECG data from four trials
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014
Current controversies in the treatment of COPD
Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD
Year: 2011
Rational monitoring of COPD: where do current clinical guidelines stand?
Source: Eur Respir J 2007; 29: 1078-1081
Year: 2007
Stepping up the controller medication in asthma patients: Impact of various treatment options on costs
Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care
Year: 2011
Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Evidence-based treatments for severe asthma
Source: Annual Congress 2011 - PG13 ERS/ACCP jointly organised: evidence-based approach to advanced respiratory care
Year: 2011
Guidelines versus clinical practice in the treatment of COPD: a reappraisal
Source: Eur Respir J 2006; 27: 656
Year: 2006
The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Diagnosis of COPD exacerbations on hospital admission: Results from the European COPD audit
Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation
Year: 2011
State-of-the-art: development of evidence-based clinical practice guidelines
Source: Annual Congress 2011 - PG13 ERS/ACCP jointly organised: evidence-based approach to advanced respiratory care
Year: 2011
Adaptation rate between COPD treatment in clinical practice and guidelines recommendations
Source: Eur Respir J 2007; 30: Suppl. 51, 779s
Year: 2007
COPD patients' expectations of ICS/LABA therapy
Source: International Congress 2014 – Management of COPD in primary care
Year: 2014
Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
New approaches for diagnosis and management of COPD
Source: Annual Congress 2010 - GOLD Update
Year: 2010
Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014
Lung cancer and COPD multidisciplinary teams: Exploring comparisons of patient perceptions
Source: Annual Congress 2010 - Optimising the care and management of patients with COPD
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept